XML 15 R6.htm IDEA: XBRL DOCUMENT v3.10.0.1
Interim Condensed Consolidated Statements of Changes in Equity - USD ($)
$ in Thousands
Share Capital
Additional paid-in capital
Retained earnings
Accumulated other comprehensive Loss
Treasury shares (cost)
Non-controlling interests
Total
Beginning balance at Dec. 31, 2016 $ 4,184 $ 100,571 $ 234,268 $ (2,377) $ (259) $ 387,455 $ 723,842
Beginning balance, Shares at Dec. 31, 2016 14,728,782            
Statement Line Items [Line Items]              
Net Income 5,754 16,809 22,563
Foreign currency translation reserve 17,017 14,529 31,546
Actuarial loss from defined benefit plans (1,030) (1,039) (2,069)
Unrealized loss on debt instruments at fair value through other comprehensive income, net 99 105 204
Realized gain on debt instruments at fair value through other comprehensive income (50) (56) (106)
Share in other comprehensive income of joint venture 102 102
Total other comprehensive income (loss) (1,030) 17,168 13,539 29,677
Total comprehensive income 4,724 17,168 30,348 52,240
Issuance of restricted shares to employees $ 3 (3)
Issuance of restricted shares to employees, shares 10,000            
Stock-based Compensation expenses 1,001 2,095 3,096
Transactions with non-controlling interests due to holding changes, including exercise of employees stock options (473) 1,309 836
Acquisition of non-controlling interests 3 3 6
Adjustments to redeemable non-controlling interests (2,758) (3,007) (5,765)
Dividend to Formula's shareholders (5,011) (5,011)
Dividend to non-controlling interests in subsidiaries (14,953) (14,953)
Ending balance at Sep. 30, 2017 $ 4,187 98,341 233,981 14,791 (259) 403,250 754,291
Ending balance, Shares at Sep. 30, 2017 14,738,782            
Beginning balance at Dec. 31, 2016 $ 4,184 100,571 234,268 (2,377) (259) 387,455 723,842
Beginning balance, Shares at Dec. 31, 2016 14,728,782            
Statement Line Items [Line Items]              
Net Income 10,352 25,417 35,769
Foreign currency translation reserve 20,325 17,109 37,434
Actuarial loss from defined benefit plans (453) (445) (898)
Unrealized loss on debt instruments at fair value through other comprehensive income, net 70 74 144
Realized gain on debt instruments at fair value through other comprehensive income (44) (50) (94)
Share in other comprehensive income of joint venture       104 104
Total other comprehensive income (loss) (453) 20,455 16,688 36,690
Total comprehensive income 9,899 20,455 42,105 72,459
Issuance of restricted shares to employees $ 3 (3)
Issuance of restricted shares to employees, shares 10,000            
Stock-based Compensation expenses 1,058 3,442 4,500
Transactions with non-controlling interests due to holding changes, including exercise of employees stock options (1,306) 4,553 3,247
Acquisition of non-controlling interests 3 3 6
Non-controlling interests arising from exercise of options in indirect subsidiary 28 28
Adjustments to redeemable non-controlling interests (2,283) (2,589) (4,872)
Redeemable non-controlling interests classification to non-controlling interests 2,440 2,440
Dividend to Formula's shareholders (5,011) (5,011)
Dividend to non-controlling interests in subsidiaries (23,717) (23,717)
Ending balance at Dec. 31, 2017 $ 4,187 98,040 239,156 18,078 (259) 413,720 $ 772,922
Ending balance, Shares at Dec. 31, 2017 14,738,782           14,738,782
Statement Line Items [Line Items]              
Impact of the adoption of IFRS 15 874 941 $ 1,815
Beginning balance (Including the impact of the adoption of IFRS 15) $ 4,187 98,040 240,030 18,078 (259) 414,661 774,737
Beginning balance, Shares (Including the impact of the adoption of IFRS 15) 14,738,782            
Net Income 21,630 27,355 48,985
Foreign currency translation reserve (9,035) (8,153) (17,188)
Actuarial loss from defined benefit plans 22 23 45
Unrealized loss on debt instruments at fair value through other comprehensive income, net (27) (28) (55)
Share in other comprehensive income of joint venture            
Total other comprehensive income (loss) 22 (9,062) (8,158) (17,198)
Total comprehensive income 21,652 (9,062) 19,197 31,787
Issuance of shares upon conversion of convertible debentures [1] 40 40
Issuance of shares upon conversion of convertible debentures, shares 979            
Stock-based Compensation expenses 155 3,136 3,291
Transactions with non-controlling interests due to holding changes, including exercise of employees stock options (421) 1,190 769
Acquisition of non-controlling interests (210) (547) (757)
Dilution due to issuance of Magic's ordinary shares 2,682 22,722 25,404
Non-controlling interests arising from initially consolidated companies 28 28
Adjustments to redeemable non-controlling interests (929) (1,056) (1,985)
Change in terms or expiration of redeemable non-controlling interests' put options 376 1,835 2,211
Dividend to Formula's shareholders (5,011) (5,011)
Dividend to non-controlling interests in subsidiaries (24,501) (24,501)
Ending balance at Sep. 30, 2018 $ 4,187 $ 99,733 $ 256,671 $ 9,016 $ (259) $ 436,665 $ 806,013
Ending balance, Shares at Sep. 30, 2018 14,739,761           14,739,761
[1] Less than one thousand U.S. dollar